AEZS

AEterna Zentaris Inc. News Headlines

$1.46
*  
0.04
2.67%
Get AEZS Alerts
*Delayed - data as of Sep. 2, 2014 14:47 ET  -  Find a broker to begin trading AEZS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AEZS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Basket Of Biotech Bargains To Buy And Hold
6/30/2014 4:23:00 PM - Seeking Alpha

Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha

Update on Coronado's TSO - Analyst Blog
12/16/2013 5:33:06 PM - Zacks.com

Endocyte Enrolls First Patient in Study - Analyst Blog
12/13/2013 7:27:01 PM - Zacks.com

SUPN Presents Data on Drugs at AES - Analyst Blog
12/13/2013 5:10:01 PM - Zacks.com

Aeterna Zentaris: Mispriced $1 Biotech Stock With Limited Downside Risk And Big Upside Potential
12/12/2013 1:15:00 PM - Seeking Alpha

ARIAD Loses as EMA Deliberates on Iclusig - Analyst Blog
12/9/2013 5:05:58 PM - Zacks.com

Update on KaloBios' KB004 - Analyst Blog
12/6/2013 7:06:12 PM - Zacks.com

Update on Pacira's Exparel - Analyst Blog
12/6/2013 7:04:54 PM - Zacks.com

NDA for AcelRx's Zalviso Accepted - Analyst Blog
12/5/2013 8:04:01 PM - Zacks.com

JAZZ Briefs at Healthcare Conference - Analyst Blog
12/5/2013 6:05:52 PM - Zacks.com

Final Guidance from NICE for pSivida's Iluvien - Analyst Blog
12/5/2013 6:00:01 PM - Zacks.com

Setback for Lexicon Pharma - Analyst Blog
12/5/2013 5:05:10 PM - Zacks.com

Data on NVO's Diabetes Drugs - Analyst Blog
12/4/2013 5:04:51 PM - Zacks.com

Sangamo Biosciences (SGMO) in Focus: Stock Rises 5.8% - Tale of the Tape
12/4/2013 9:53:58 AM - Zacks.com

Biogen's Hemophilia B Drug Approval Delayed - Analyst Blog
12/3/2013 5:50:01 PM - Zacks.com

Actelion's Update on Opsumit - Analyst Blog
12/3/2013 5:45:01 PM - Zacks.com

Aeterna Zentaris Closes Public Offering - Analyst Blog
12/2/2013 5:53:39 PM - Zacks.com

New Data on Aegerion's Juxtapid - Analyst Blog
11/19/2013 8:06:33 PM - Zacks.com

U.S. Launch of Actelion's Valchlor - Analyst Blog
11/19/2013 5:45:01 PM - Zacks.com

Zacks #5 Rank Additions for Tuesday - Tale of the Tape
11/19/2013 10:07:15 AM - Zacks.com

Billionaires Hold Waning Biotechs 42% Off
10/13/2013 5:18:59 PM - GuruFocus

Update on Aeterna Zentaris' Cetrotide - Analyst Blog
10/4/2013 5:32:16 PM - Zacks.com

AEterna Zentaris: An Interesting Investment With Long-Term Growth Potential
8/20/2013 10:42:00 AM - Seeking Alpha

Aeterna Initiates Phase III Study on AEZS-108 - Analyst Blog
8/2/2013 6:07:24 PM - Zacks.com